益气清肝汤联合恩替卡韦治疗慢性乙型肝炎肝纤维化的临床研究

目的观察益气清肝汤联合恩替卡韦治疗慢性乙型肝炎肝纤维化的临床疗效。方法慢性乙型肝炎肝纤维化76例随机分为对照组和观察组,观察组采用益气清肝汤联合恩替卡韦进行治疗,对照组采用恩替卡韦治疗。观察治疗后两组血清肝纤维化指标和主要临床症状的变化情况。结果两组患者肝纤维化指标均较治疗前明显下降（P〈0.05）;治疗结束时观察组纤维化指标变化值与对照组比较差异有统计学意义（P〈0.05）。两组患者经治疗后血清HBV-DNA水平均明显下降,但转阴率无明显差异（P〉0.05）;两组主要临床症状均有明显改善,其中观察组在纳差和皮肤巩膜黄染消退方面显著优于对照组（P〈0.05）。结论益气清肝汤联合恩替卡韦治疗慢性乙型肝炎肝纤维化临床疗效较单独使用恩替卡韦更好。

Clinical therapeutic effect of Yi Qi Qing Gan Tang combined with entecavir on hepatic fibrosis of chronic hepatitis B

Objective To evaluate the clinical therapeutic effect of Yi Qi Qing Gan Tang combined with entecavir on hepatic fibrosis of chronic hepatitis B.Methods 76 patients with hepatic fibrosis of chronic hepatitis B were randomly divided into the group treated entecavir(0.5 mg/d) combined with Yi Qi Qing Gan Tang(n=39),and the control group treated entecavir(n=37,0.5 mg/d).Serum fibrosis markers and major changes in clinical symptoms were observed after 48 weeks.Results The serum HBV-DNA levels and liver fibrosis of patients in two groups were significantly decreased after treating(P<0.05).No significant difference of the serum HBV-DNA levels was found between two groups(P>0.05).The clinical symptoms were significantly improved.The anorexia and yellowish discoloration of skin in treatment group were significantly better than that in the control group(P<0.05).Conclusion Yi Qi Qing Gan Tang combined with Entecavir has a good effect on liver cirrhosis of HBV.